Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Health Care

What will drive the S&P 500 this fall

Tech's market dominance waned in the third quarter.

The Street

Is Procter & Gamble a Dividend Stock to Buy Now?

While Procter & Gamble (PG) topped earnings estimates for the third quarter, the company’s net sales disappointed. Despite its mixed quarterly results, the consumer giant increased its full-year outlook for earnings growth. With a track record of 68 consecutive years of dividend increases, should you consider investing in PG now?…

StockNews.com

Alibaba reports mixed results, plans share buyback to boost growth

Alibaba reports mixed results with strong growth in China E-Commerce, increased share buyback program, and focus on improving user experience. Asian equiti...

Top News

From analysis to the latest developments in health,
read the most diverse news in one place.

Major Stock Indexes are Mixed; Health Care Stocks Lead, But These Leaders Break Down

Health care and biotech stocks are showing strength.

Investors Business Daily

Procter & Gamble Q3 Earnings Top Estimates; Raises FY22 Top-Line Guidance

Procter & Gamble Co (NYSE:PG) reported third-quarter FY22 sales growth of 7.1% year-on-year to $19.38 billion, beating the consensus of $18.73 billion. Organic sales increased 10%, driven by a 3% increase in shipment volume, 5% from improved pricing, and a 2% increase from geographic and product mix. Sales in the beauty segment rose…

Benzinga

10 Companies Are Hiring Like Crazy And Investors Aren't Pleased

America's hiring, and that's supposedly a positive for the economy. But investors are punishing shares of S&P 500 companies adding the most.

Investors Business Daily

Analysts Think You're Crazy Not Owning 13 High-Dividend Stocks

What good is a big dividend if the stock keeps falling? Analysts see ways to score dividends on some S&P 500 stocks bucking the sell-off.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Gillette Maker Procter & Gamble Q2 Earnings Top Estimates

Procter & Gamble Co (NYSE:PG) reported second-quarter FY22 sales growth of 6.12% year-on-year, to $20.95 billion, beating the analyst consensus of $20.34 billion. Organic sales increased 6%, driven by a 3% increase in shipment volume, a 3% increase in pricing to help offset the significant commodity and other input cost increases. Sales in…

Benzinga

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

SP Global Market Intelligence

The Procter Gamble Company

14 stories

Pilgrim Pride

13 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.